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Introduction 
Previous investigations have shown that creatine supple-
mentation provides an ergogenic effect for various mea-
sures of anaerobic exercise performance. In particular, it 
has been demonstrated that short-term loading (20–25 g 
· d-1, 5–7 days) or long-term chronic doses (3 g· d-1, ≥30 
days) of creatine monohydrate (CM) can lead to improve-
ments in one-repetition maximum (1RM) strength, muscu-
lar endurance, anaerobic power, speed, and sprinting per-
formance (5,15,17,19,22,24,25,32–34,36). Traditionally, the 
methods used to assess these variables include dynamic 
constant external resistance exercises (i.e., free weights, 
weight machines) and anaerobic performance measures 
such as the Wingate test (5,15,19). In addition, the major-
ity of these studies (5,15,17,19,22,24,25,32–34,36) have in-
cluded resistance training during the supplementation pe-
riod and have used cycle ergometry, not running, to assess 
sprinting performance. There are limited data, however, 
regarding the influence of creatine supplementation on 
standardized field assessments of power, lateral speed, 
agility, and change-of-direction ability that are commonly 
used to predict athletic performance. Based on the short-
duration high-intensity nature of frequently used tests 
such as the broad and vertical jumps, 40-yard dash, 20-
yard shuttle run, and 3-cone drill, it is likely that sup-
plementation with creatine would serve as an effective 
ergogenic aid for these activities. For example, the phys-
iological benefits of creatine supplementation have been 
attributed to enhanced adenosine triphosphate (ATP) re-
generation, shortened muscle relaxation time, improved 
efficiency of cross-bridge cycling (35), and body composi-
tion (17,22,28,36). Therefore, it is possible that these ad-
aptations would facilitate the maximal, and often repeti-
tive, muscular contractions associated with standardized 
field assessments (i.e., broad and vertical jumps, 40-yard 
dash, 20- yard shuttle run, 3-cone drill), thereby improv-
ing performance in these areas. 
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Abstract 
The purpose of this study was to examine the effects of 28 days of polyethylene glycosylated creatine (PEG-creatine) sup-
plementation (1.25 and 2.50 g · d-1) on anaerobic performance measures (vertical and broad jumps, 40-yard dash, 20-yard 
shuttle run, and 3-cone drill), upper- and lower-body muscular strength and endurance (bench press and leg extension), 
and body composition. This study used a randomized, double-blind, placebo controlled parallel design. Seventy-seven adult 
men (mean age ± SD, 22.1 6 2.5 years; body mass, 81.7 ± 10.8 kg) volunteered to participate and were randomly assigned 
to a placebo (n = 23), 1.25 g ·  d-1 of PEG-creatine (n = 27), or 2.50 g · d-1 of PEG-creatine (n = 27) group. The subjects per-
formed anaerobic performance measures, muscular strength (one-repetition maximum [1RM]), and endurance (80% 1RM) 
tests for bench press and leg extension, and underwater weighing for the determination of body composition at day 0 (base-
line), day 14, and day 28. The results indicated that there were improvements (p , 0.0167) in vertical jump, 20-yard shut-
tle run, 3-cone drill, muscular endurance for bench press, and body mass for at least one of the PEG-creatine groups with-
out changes for the placebo group. Thus, the present results demonstrated that PEG-creatine supplementation at 1.25 or 
2.50 g · d-1 had an ergogenic effect on lower-body vertical power, agility, change-of-direction ability, upper-body muscular 
endurance, and body mass. 
Keywords: PEG, supplements, strength, endurance 
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Polyethylene glycol (PEG) is a nontoxic water-soluble 
polymer that is commonly bound to various substances 
and functions as a delivery system to enhance the ab-
sorption of medications (3), vitamins (23), and nutritional 
supplements including creatine (5,12,19) and L-arginine 
(6,7). When attached to PEG, creatine has been shown 
to have greater uptake efficiency (12) and provide ergo-
genic effects with smaller supplementation doses com-
pared with CM (19). Specifically, Herda et al. (19) estab-
lished that supplementation with 1.25 and 2.50 g· d-1 of 
PEG-creatine for 30 days without concurrent resistance 
training improved measures of upper- and lower-body 
strength to the same extent as 5 g · d-1 of CM. It is possi-
ble that these findings (19) were attributable, in part, to 
changes in body composition leading to greater muscular 
strength. In particular, recent investigations have shown 
that supplementation with creatine may promote favor-
able effects on fat-free mass (FFM) by stimulating pro-
tein synthesis (36) and inhibiting protein catabolism (28). 
Thus, in addition to the ergogenic effects related to en-
hanced ATP regeneration and subsequent ability to main-
tain high-intensity exercise, PEG-creatine supplemen-
tation may provide improvements in body composition 
that are not associated with those of resistance training. 
Based on these mechanisms, it is possible that supplemen-
tation with PEG-creatine would improve the short-dura-
tion, high-intensity standardized field assessments of an-
aerobic performance. Therefore, the purpose of this study 
was to examine the effects of 28 days of PEG-creatine sup-
plementation (1.25 and 2.50 g· d-1) on anaerobic perfor-
mance measures (vertical and broad jumps, 40-yard dash, 
20-yard shuttle run, and 3-cone drill), upper- and lower-
body muscular strength and endurance (bench press and 
leg extension), and body composition. 
Methods 
Experimental Approach to the Problem 
This study used a randomized, double-blind, placebo con-
trolled parallel design. During the first laboratory visit, 
each subject performed anaerobic performance measures 
including vertical jump, broad jump, 40-yard dash, 20-yard 
shuttle run, and 3-cone drill that have commonly been used 
at the National Football League Scouting Combine. Pro-
cedures used for these anaerobic performance measures 
were consistent with those previously reported (26,29,30). 
After 24 hours, each subject returned to the laboratory to 
complete the second visit (day 0) that involved assessment 
of muscular strength (1RM) and endurance (maximal num-
ber of repetitions completed at 80% 1RM) for the bench 
press and bilateral leg extension exercises. In addition, 
during the second laboratory visit, each subject performed 
underwater weighing for the determination of body com-
position and was randomly assigned to one of 3 groups: (a) 
placebo (n = 23); (b) 1.25 g · d–1 of PEG-creatine (PEG1.25; 
n = 27); or (c) 2.50 g · d–1 of PEG-creatine (PEG2.50; n = 
27). The ingredients for the supplement included 1.25 g or 
2.50 g of PEG-creatine, whereas the placebo consisted of 
microcrystalline cellulose. The subjects were asked to in-
gest 1 dose (4 tablets) every day with approximately 0.5 
L of water for 28 days. After 2 weeks of supplementation 
(day 14), the subjects returned to the laboratory for vis-
its 3 and 4 (separated by 24 hours) to perform the anaer-
obic performance measures, muscular strength and endur-
ance exercises, and underwater weighing using the same 
protocol as during the baseline measurements. After 2 ad-
ditional weeks of supplementation (day 28), the testing 
procedures were repeated during the fifth and sixth labo-
ratory visits (separated by 24 hours). During the course of 
the study, the subjects were encouraged to continue with 
their normal exercise and dietary habits. Subjects were 
also instructed to refrain from exercise for 48 hours be-
fore each laboratory visit. Furthermore, each subject com-
pleted a 3-day food log during the first and last week of 
the supplementation period to ensure there were no sig-
nificant changes in total caloric (kcal), protein, carbohy-
drate, and fat intake. 
Subjects 
Seventy-seven adult men (mean age ± SD, 22.1 ± 2.5 years; 
body mass, 81.7 ± 8.4 kg; height, 181.7 ± 5.3 cm) volun-
teered to participate in this investigation. The subjects 
were untrained in resistance exercise and engaged in no 
more than 4 hours of recreational activity per week. All of 
the subjects were University of Nebraska undergraduate or 
graduate students. Data collection was performed during 
the fall semester. In addition, the subjects did not report 
or exhibit any of the following that could have significantly 
affected the outcome of the study: (a) a history of medical 
or surgical events, including cardiovascular disease, met-
abolic, renal, hepatic, or musculoskeletal disorders; (b) 
use of any medication; (c) use of nutritional supplements; 
or (d) participation in another clinical trial or ingestion 
of another investigational product within thirty days be-
fore screening/ enrollment. The study was approved by the 
University Institutional Review Board for Human Subjects, 
and all participants completed a health history question-
naire and signed a written informed consent document be-
fore the testing. 
Procedures 
Vertical Jump. Vertical jump height was measured using 
the Vertec vertical jump device (Gill Athletics, Champaign, 
IL, USA). Each subject was positioned directly underneath 
the Vertec and instructed to jump as high as possible from 
a standing 2-foot position and move the highest horizon-
tal vane with a single hand (29). Each subject performed 
3 vertical jumps with 2 minutes of rest between each trial. 
Vertical jump height was calculated as the difference be-
tween the highest vane of the Vertec reached and the 
standing reach height. 
Effects of Polyethylene Glycosylated Creatine Supplementation  827
Broad Jump.
The standing broad jump test involved each subject stand-
ing in a 2-foot position with their toes directly behind the 
starting line and jumping forward for maximal horizontal 
distance. The standing broad jump distance was measured 
as the farthest horizontal distance reached by the land-
ing contact point of the heel from the starting line (29). 
Each subject performed 3 standing broad jump trials with 
2 minutes of rest between each trial. 
40-Yard Dash. 
The 40-yard dash involved measuring the time (hand timed 
by the same investigator) required to sprint 40 yards as 
fast as possible. Each subject was positioned in a 3- point 
stance behind the starting line and was instructed to sprint 
the distance of 40 yards as fast as possible. Two cones 
were used to represent the starting line, and 2 cones were 
placed 40 yards down field to represent the finishing line 
that each subject was instructed to run through. Subjects 
performed two 40-yard dash time trials separated by 2 
minutes with the fastest time used as the representative 
40-yard dash time. 
20-Yard Shuttle Run. 
The shuttle run involved each subject completing 20 to-
tal yards of lateral movement with 2 changes in direction 
in the fastest time possible. The starting position involved 
each subject straddling the middle of 3 parallel lines spaced 
5 yards apart from one another. From the starting (middle) 
line, the subject ran 5 yards to the right, touched the far-
thest right line with their right hand, quickly changed di-
rection, and ran 10 yards back to the left passing the start-
ing line. After reaching down and touching the far left line 
with their left hand, the subject again changed direction 
and sprinted 5 yards to the right passing the starting line 
(29). Each subject performed 2 trials separated by 2 min-
utes of rest. The shuttle run time was recorded as the fast-
est time required to complete the 20-yard course. 
3-Cone Drill. 
The 3-cone drill involved each subject running a specific 
route around 3 cones placed 5 yards apart in an “L” forma-
tion (30). Each subject performed 2 trials separated by 2 
minutes of rest. The fastest time required to complete the 
course was used as the representative 3-cone drill time. 
Muscular Strength and Endurance. 
The 1RM dynamic constant external resistance (DCER) 
muscular strength was determined for the leg extension 
(1RMLE) and bench press (1RMBP) exercises. The leg exten-
sion exercises were performed on a plate-loaded leg exten-
sion resistance training machine (Body-Solid, Forest Park, 
IL, USA). Each subject sat with their back flat against the 
backrest and was instructed to hold tightly to the handles 
of the device. The backrest was adjusted to align the an-
atomical axes of the knee with the mechanical axis of the 
machine. The subject’s legs were placed against shin pads 
that were attached to the lever arm of the machine. The 
distance between the shin pads and the axis of rotation 
of the lever arm was fixed and not adjustable. The posi-
tioning of each subject, however, was consistent across 
all tests. The bench press exercises were performed on a 
standard free-weight bench (Body Power, Williamsburg, 
VA, USA) with an Olympic bar. After receiving a lift-off 
from a spotter, the subject lowered the bar to their chest, 
paused briefly, and then pressed the bar to full extension 
of the forearms. For both the leg extension and bench press 
exercises, 1RM DCER strength was determined by apply-
ing progressively heavier loads until the subject could not 
complete a repetition through the full range of motion. Ad-
ditional trials were performed with lighter loads until the 
1RM was determined within 2.27 kg, and this was typically 
achieved within 5 trials. Two minutes of rest were allowed 
between all trials. For the leg extension (REPLE) and bench 
press (REPBP) endurance testing, subjects performed as 
many repetitions as possible of full extension of the legs 
and forearms at 80% of their baseline (day 0) 1RM. Dur-
ing day 0, day 14, and day 28, the same procedures for leg 
extension and bench press testing were performed. The 
test-retest reliability data from our laboratory for leg ex-
tension and bench press strength testing indicated that for 
adult male subjects (n = 20) measured 8 weeks apart, the 
intraclass correlations (ICC) were 0.98 and 0.99, respec-
tively, with no significant (p > 0.05) mean differences be-
tween test and retest values. 
Underwater Weighing. 
Body density was assessed from underwater weighing 
(UWW), with correction for residual lung volume (RV) us-
ing the oxygen dilution method of Wilmore (38). Resid-
ual lung volume was determined with the subject seated 
in a position similar to that assumed during UWW. The av-
erage of similar scores (within 100 mL) from 2 to 3 trials 
was used as the representative RV. Underwater weight was 
measured in a hydrostatic weighing tank in which a nylon 
swing seat was suspended from a 10-kg Salter scale (REGO 
Designs & Patents, model 230). The average of the 3 high-
est values from 6 to 10 trials was used as the representa-
tive underwater weight. Percent body fat (% fat) was cal-
culated using the formula of Brozek et al. (4), with fat mass 
and FFM derived mathematically. Previous test retest reli-
ability data for UWW from our laboratory for % fat indi-
cated that for young adult male subjects (n = 16) measured 
24–72 hours apart, the ICC was 0.98, with a standard error 
of measurement of 0.9% fat and no significant (p > 0.05) 
mean differences between test and retest values. 
Statistical Analyses 
Vertical jump, broad jump, 40-yard dash, 20-yard shut-
tle run, and 3-cone drill times as well as 1RMBP, 1RMLE, 
REPBP, REPLE, body mass, % fat, fat mass, FFM, were an-
alyzed with separate 3 X 3 mixed factorial analysis of 
variance (ANOVAs) (time [day 0, day 14, day 28] X group 
[placebo, 1.25 g · d–1, 2.50 g· d-1]). In addition, 1-way fol-
low-up repeated measures ANOVAs across time for a priori 
planned comparisons by group were conducted and post 
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hoc analyses included paired sample t-tests with Bonfer-
roni corrections (0.05/3 = 0.0167). An alpha of p < 0.05 
was considered statistically significant for all interaction 
effects and follow-up ANOVAs. In addition, the total caloric 
(kilocalories) and macronutrient (grams of protein, car-
bohydrate, and fat) intake were analyzed with separate 2 
(time [day 0, day 28]) X 3 (group [1.25 g · d–1, 2.50 g · d–1, 
placebo]) mixed factorial ANOVAs. 
Results 
The results of the statistical analyses for the performance 
measures at day 0, 14, and 28 for the placebo, PEG1.25, and 
PEG2.50 groups are provided in Table 1. The findings in-
dicated that there were significant increases in vertical 
jump (PEG1.25 and PEG2.50), REPBP (PEG1.25 and PEG2.50), 
and body mass (PEG1.25 and PEG2.50), without changes for 
the placebo group. There were also significant decreases 
in the 20-yard shuttle run (PEG1.25 and PEG2.50) and 3-cone 
drill (PEG2.50), without changes for the placebo group. For 
broad jump, 40-yard dash, 1RMBP, 1RMLE, REPLE, and FFM, 
however, there were changes for all 3 groups (placebo, 
PEG1.25, and PEG2.50). There were no changes in % fat, fat 
mass, total calories, or macronutrients consumed for any 
of the groups. 
Discussion 
The findings of the present investigation indicated that 
supplementation with 1.25 or 2.50 g · d–1 of PEG-creatine 
led to significant improvements in vertical jump, 20-yard 
shuttle run, 3-cone drill, REPBP, and body mass (Table 1). 
For broad jump, 40-yard dash, 1RMBP, 1RMLE, REPLE, and 
FFM, however, there were no significant differences among 
both PEG-creatine groups (1.25 and 2.50 g· d21) and the 
placebo group. Thus, the results of this study demonstrated 
that PEG-creatine supplementation had an ergogenic effect 
on lower-body vertical power, upper-body muscular endur-
ance, agility, change-of-direction ability, and body mass, 
but not on speed, upper-body muscular strength, lower-
body horizontal power, muscular strength, or endurance. 
In general, previous studies (21,27) have shown that 
short-term creatine supplementation without resistance 
training had no influence on vertical jump performance. 
For example, Izquierdo et al. (21) found that 5 days of 
loading (20 g · d–1) with CM did not improve vertical jump 
height in a sample of male handball players (n = 19). Mu-
jika et al. (27) also determined that 6 days of CM loading 
(20 g · d–1) resulted in no change in vertical jump (47.4 6 
6.0 cm to 46.8 6 6.0 cm) in male soccer athletes (n = 17). 
It has been suggested (27) that short-term creatine load-
ing may not be beneficial for performances related to over-
coming gravity such as vertical jump, because of the asso-
ciated increase in body mass caused by water retention. 
Furthermore, because of the short duration (i.e., ,1 sec-
ond) in performing a vertical jump, it is likely that phos-
phocreatine stores are not the limiting factor for this ac-
tivity, and therefore, may not be influenced by CM loading 
(25). In combination with resistance training, how ever, 
longer-term supplementation with creatine may lead to 
improvements in vertical jump as the result of increased 
FFM (27,32). This suggestion is supported by the find-
ings of Haff et al. (17) and Kirksey et al. (22) that demon-
strated concurrent increases in vertical jump performance 
and FFM after 6 weeks of creatine supplementation (0.3 
g · kg-1 · d-1) and resistance training in track and field ath-
letes. In this investigation, there were significant increases 
in vertical jump after 28 days of supplementation for the 
PEG1.25 (63.0 ± 1.5 cm to 65.8 ± 1.4 cm) and PEG2.50 (58.7 
± 1.8 cm to 61.0 ± 2.0 cm) groups, but no change (58.9 ± 
1.8 cm to 60.7 ± 1.8 cm) in the placebo group. Therefore, 
although we did not use a concurrent resistance training 
program, it is possible that the changes in vertical jump for 
the PEGcreatine groups were related to the increased FFM 
(PEG1.25: 67.8 ± 1.4 kg to 69.0 ± 1.4 kg; PEG2.50: 67.7 ± 1.5 
kg to 69.0 ± 1.5 kg) from day 0 to day 28. In contrast, how-
ever, the placebo group also exhibited increased FFM (66.7 
± 1.2 kg to 67.5 ± 1.3 kg) over the same time period, but 
experienced no improvement in vertical jump. It is possi-
ble that these findings were related to the amount of abso-
lute change in FFM among the PEG1.25 (+1.2 kg), PEG2.50 
(+1.3 kg), and placebo groups (+0.8 kg). The present re-
sults also indicated that there were no improvements in 
broad jump performance at day 14 or day 28 for the PEG1.25 
or PEG2.50 groups when compared with the placebo group. 
Both vertical jump and broad jump have been described 
as measures of lower-body power and have been shown to 
be moderately correlated (r = 0.74) (29). Based on these 
findings (29), we hypothesized that the creatine-induced 
changes in performance would be similar between verti-
cal jump and broad jump. The mechanism responsible for 
the discrepancy in the results remains uncertain, but may 
have been because of the relatively smaller doses of PEG-
creatine (1.25 and 2.50 · g d-1) used in this study compared 
with previous investigations (22,24,25,34,36) that have 
used large loading doses of CM and shown improvements 
in lower body power. Future studies should further exam-
ine the effects of PEG-creatine on vertical and broad jump 
performance using larger doses or longer supplementa-
tion periods. 
The results of this investigation indicated there were 
significant decreases in 40-yard dash time from day 0 to 
day 28 for the PEG1.25 (5.43 ± 0.06 seconds to 5.13 ± 0.06 
seconds) and PEG2.50 (5.60 ± 0.08 seconds to 5.23 ± 0.06 
seconds) groups as well as the placebo group (5.53 ± 0.07 
seconds to 5.27 ± 0.06 seconds). In general, the findings of 
previous studies (11,14,32) have suggested that the ergo-
genic effect of creatine supplementation on sprinting per-
formance may vary based on differences in training sta-
tus, athletic sample examined, sprint distance assessed, 
or addition of a concurrent resistance training program. 
For example, Glaister et al. (14) found no improvements 
for 30-meter dash time after 5 days of loading with CM 
(20 g · d–1) in a sample (n = 21) of college-aged men who 
regularly participated in multiple sprint activities. Delec-
luse et al. (11) also reported no change in 40-meter dash 
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performance (5.09 ± 0.09 seconds to 5.08 ± 0.10 seconds) 
after 7 days of loading (0.35 g · kg-1 · d-1) with CM in elite 
college sprinters (n = 7). The authors (11) contented that 
the mechanisms underlying the benefits of creatine sup-
plementation may already be optimized in highly trained 
sprinters because of multiple years of intensive sprint 
training. This suggestion (11), however, is not consistent 
with the findings of Skare et al. (31) that indicated 20 g · 
d-1 of CM for 5 days decreased 60-m and 100-m (11.68 ± 
0.27 seconds to 11.59 ± 0.31 seconds) times in a sample 
of sprinters (n = 9) during a concurrent resistance train-
ing program. Stout et al. (32) also found improvements 
in 100-yard dash time (12.13 ± 0.36 seconds to 11.82 ± 
0.37 seconds) after 8 weeks of supplementation with CM 
(21 g ·  d-1 for 5 days, 10.5 g · d-1 thereafter) in resistance-
trained college football players. It has been demonstrated 
that creatine supplementation with resistance training 
provides greater improvements in performance compared 
with just creatine supplementation or resistance training 
alone (1). These findings (1) offer a plausible explanation 
for the ergogenic effects observed after supplementation 
with CM in the resistance-trained athletes of Stout et al. 
(32) and Skare et al. (31) compared with the lack of im-
provement in the participants of this investigation and pre-
vious studies (11,14) who were not engaged in a concur-
rent resistance training program during the course of the 
study. In conjunction, the present findings and those of 
others (11,14,31,32) suggested that creatine supplementa-
tion may improve 40- and 100-yard dash performance only 
when combined with resistance-training. 
To the best of our knowledge, no previous investiga-
tions have examined the effects of creatine supplemen-
tation on the 20-yard shuttle run and 3-cone drill, which 
have been described as performance measures related to 
anaerobic power, speed, change-of-direction ability, and 
agility (26,29). Our results demonstrated there were sig-
nificant decreases in shuttle run times for the PEG1.25 group 
from day 0 (5.04 ± 0.05 seconds) and day 14 (5.03 ± 0.05 
seconds) to day 28 (4.83 ± 0.04 seconds); and PEG2.50 
group from day 0 (5.08 ± 0.06 seconds) to day 14 (4.97 ± 
0.04 seconds) day 28 (4.86 ± 0.05 seconds). In addition, 
there were significant decreases in 3-cone drill time for the 
PEG2.50 group from day 0 (8.55 ± 0.09 seconds) to day 14 
(8.31 ± 0.07 seconds) and day 28 (8.31 ± 0.08 seconds), 
but not the PEG1.25 or placebo groups. The physiological 
mechanisms that were responsible for faster 20-yard shut-
tle run and 3-cone drill performances may be related to the 
shortened muscle relaxation time associated with CM sup-
plementation (35). Specifically, the findings of van Leem-
putte et al. (35) suggested that greater intracellular stores 
of phosphocreatine would lead to improved efficiency of 
sarcoplasmic Ca++-ATPase activity and cross-bridge cy-
cling, thereby decreasing the energy costs of human skel-
etal muscle relaxation. It is possible that these adaptations 
would contribute to increased power production by skel-
etal muscle and enable maximal, high-intensity muscular 
contractions to continue for a greater period of time (35). 
In theory, the proposed mechanisms would facilitate the 
rapid and repeated muscle actions required during the 20-
yard shuttle run and 3-cone drill, leading to enhanced per-
formance in these activities. Future studies should further 
examine the effects of creatine supplementation on phys-
ical measures involving multiple high-intensity muscular 
contractions associated with change-of-direction ability 
and agility. The findings of this study, however, indicated 
that supplementation with 2.50 g · d-1 of PEG-creatine pro-
vided an ergogenic effect for the 20-yard shuttle run and 
3-cone drill. 
Recent investigations (13,34,39) have reported conflict-
ing results regarding the effect of creatine supplementa-
tion without concurrent resistance training on muscular 
strength. For example, it has been demonstrated that 25 
g · d-1 of CM for 5 days increased concentric, isokinetic 
peak torque of the leg extensors at 1808 · s-1(34), but 20 
g · d-1 over the same time period resulted in no change 
(13). In addition, loading doses of 20 g · d-1 for 5 days have 
been shown to increase 1RM half-squat, but not 1RMBP (21). 
Zuniga et al. (39) also examined loading doses of 20 g · d-1 
of CM and found no improvements in 1RMLE or 1RMBP af-
ter 7 days of supplementation. Other studies (5,19) involv-
ing non-loading chronic doses of PEG-creatine (1.25–5.00 
g · d-1) and the assessment of muscular strength have also 
provided inconsistent results, particularly between upper- 
and lower-body 1RM measures. Specifically, 4 weeks of 
supplementation with 1.25, 2.50, and 5.00 g · d-1 of PEG-
creatine has been shown to improve 1RMBP (5,19). For 
measures of lower body strength, however, these investi-
gations found that 1.25 and 2.50 g · d–1 increased 1RM leg 
press (19), but 5.0 g · d-1 had no effect on 1RMLE (5). In 
this investigation, there were increases in both 1RMBP and 
1RMLE from day 0 to day 28 for the PEG1.25, PEG2.50, and 
placebo groups. Collectively, the present findings and those 
of others (5,13,19,21,34,39) indicated that chronic doses 
(1.25–5.0 g · d-1) of PEG-creatine and loading doses of CM 
up to 20 g · d–1 may not improve lower-body strength when 
assessed with the leg extension exercise. Furthermore, in 
contrast to Herda et al. (19), the results of this investi-
gation also demonstrated that supplementation with 1.25 
and 2.50 g · d-1 of PEG-creatine, like loading doses of CM 
(20 g · d-1) (21,39), may not increase upper-body muscu-
lar strength without resistance training. 
Creatine supplementation largely benefits exercise 
performance through enhanced levels of phosphocre-
atine within the muscle that facilitate the regeneration 
of ATP from ADP by means of creatine kinase. Therefore, 
this mechanism would primarily be useful during repeated 
bouts of high intensity activity and enable larger volumes 
of work to be accomplished during resistance training with 
subsequent increases in muscular strength and endurance. 
Previous studies have shown that typical loading periods 
(20 g · d-1 for 5–7 days) (18) and smaller chronic doses 
(3 g · d-1 for 28 days) (20) of CM can elevate intramuscu-
lar phosphocreatine and total creatine stores to ergogenic 
levels. In addition, Fry et al. (12) demonstrated through 
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biopsies that 10 g · d-1 of PEG-creatine was associated with 
a significantly greater creatine uptake efficiency in skele-
tal muscle compared with 20 g · d-1 of CM over a 5-day sup-
plementation period. Therefore, the authors (12) suggested 
that relatively smaller doses of PEG-creatine may improve 
measures of exercise performance to similar levels com-
pared with larger doses of CM. Subsequently, Herda et al. 
(19) established that 30 days of supplementation with 1.25 
and 2.50 g · d-1 of PEG-creatine provided ergogenic ef-
fects on 1RMBP and 1RM leg press equal to those from 5.0 
g · d-1 of CM. Based on these findings (12,19), we hypoth-
esized that 28 days of supplementation with the current 
PEG-creatine doses (1.25 and 2.50 g · d-1) would result in 
increased 1RMBP and 1RMLE. The physiological mechanism 
associated with PEG-creatine supplementation that is re-
sponsible for improving 1RMBP and 1RM leg press, but not 
1RMLE remains uncertain. Specifically, dosing regimens 
as low as 1.25 g · d-1 of PEG-creatine have resulted in in-
creased 1RMBP and 1RM leg press; whereas, 1.25–5.00 g · 
d-1 has not led to improved 1RMLE. Thus, the present find-
ings and those of others (5,13,19,34,39) have indicated that 
supplementation with PEG-creatine or CM may not influ-
ence measures of upper- and lower-body strength in sim-
ilar manners. 
In this investigation, muscular endurance was assessed 
as the maximum number of repetitions completed using 
80% of the baseline (day 0) 1RM for both bench press and 
leg extension. Our results indicated that there were in-
creases in REPBP from day 0 to day 28 for the PEG1.25 (7.4 
± 0.6 to 9.3 ± 0.5) and PEG2.50 (8.7 ± 0.5 to 10.6 ± 0.6) 
groups, but no change in the placebo group (8.0 ± 0.4 to 
8.9 ± 0.4). For REPLE, however, there were increases from 
day 0 to day 28 for all 3 groups (PEG1.25, 12.8 ± 0.8 to 19.7 
± 1.6; PEG2.50, 12.8 ± 1.0 to 18.3 ± 1.6; placebo, 13.2 ± 0.9 
to 18.6 ± 1.8). Previous studies have shown that short-
term high-dosage CM supplementation (21,37), but not 
chronic low doses of PEG-creatine (19), improve upper- 
and lower-body muscular endurance. For example, load-
ing with 20 g · d-1 of CM for 5 days increased muscular en-
durance at 60% 1RM for bench press (16.1 ± 2.9 to 18.8 ± 
3.5) and 70% 1RM for half squat (13.2 ± 3.0 to 15.9 ± 2.1) 
(21). Warber et al. (37) also found that 24 g · d-1 of CM for 
5 days resulted in significant increases in bench press rep-
etitions to failure at 70% of 1RM (5 set total, 43.7 ± 6.9 to 
50.7 ± 6.9) compared to placebo (41.4 ± 5.9 to 44.3 ± 5.9). 
Herda et al. (19), however, demonstrated that increases in 
bench press endurance (80% 1RM) and leg press endur-
ance (80% 1RM) after 30 days of supplementation with 5 
g · d-1 of CM, 1.25 g · d-1 of PEGcreatine, and 2.50 g · d-1 of 
PEG-creatine were not significantly different from those 
observed in the placebo group. Therefore, the results of 
this study and Herda et al. (19) suggested that the influ-
ence of low-dose (1.25–2.50 g · d-1) PEG-creatine supple-
mentation on muscular endurance in untrained individu-
als has not been clearly established. Furthermore, similar 
to previously reported findings on muscular strength, it is 
possible that supplementation with PEGcreatine may not 
influence measures of upper- and lower body muscular en-
durance in the same manner. 
Although there is conflicting evidence (2,15,39), a 
number of previous studies (8–10,13,16,21,27,36,37) have 
shown increases in body mass of 1–2 kg after typical load-
ing periods (5–6 days, 20–24 g · d-1) with CM. In this inves-
tigation, the PEG1.25 group exhibited increased body mass 
from day 0 (79.8 ± 2.0 kg) to day 28 (80.7 ± 2.0 kg), but 
not at day 14 (80.2 ± 2.0 kg). In addition, the PEG2.50 group 
had increased body mass from day 0 (81.3 ± 2.1 kg) to day 
14 (82.2 ± 2.1 kg) and day 28 (82.7 ± 2.1 kg). Changes 
in body mass that are commonly observed with CM sup-
plementation have been attributed to increased body wa-
ter content as the result of increased cellular osmolarity 
(20,36). Other findings (28,36), however, have suggested 
that creatine supplementation may also promote increases 
in FFM that are independent of those achieved with resis-
tance training. For example, the cellular swelling that oc-
curs during creatine supplementation because of increased 
intracellular water accumulation may serve as a “universal 
anabolic signal” (p. 140), thereby stimulating myofibrillar 
protein synthesis (36). The findings of Parise et al. (28) 
have also indicated that creatine may indirectly provide 
anabolic effects through the inhibition of protein catabo-
lism. In this study, however, there were increases in FFM 
over the 28-day supplementation period for the PEG1.25 
(67.8 ± 1.4 to 69.0 ± 1.4 kg), PEG2.50 (67.7 ± 1.5 to 69.0 
± 1.5 kg), and placebo (66.7 ± 1.2 to 67.5 ± 1.3 kg) groups. 
Based on these findings and the time course (28 days) of 
this study, it is likely that the changes in body mass for the 
PEG-creatine groups were the result of increased intramus-
cular water, phosphocreatine, or glycogen. Future studies 
should further examine the relationships among PEG-cre-
atine supplementation and body composition using vari-
ous dosing protocols. 
In summary, the present results indicated that supple-
mentation with PEG-creatine led to improvements in verti-
cal jump, 20-yard shuttle run, 3-cone drill, REPBP, and body 
mass. Future studies should further examine the effects of 
PEG-creatine supplementation on standardized anaerobic 
performance measures, muscular strength and endurance 
as well as body composition using larger doses or longer 
supplementation periods. 
Practical Applications 
The results from this study indicated that PEG-creatine 
supplementation (1.25 or 2.50 g · d-1) improved lower-
body vertical power, upper-body muscular endurance, 
agility, change-of-direction ability, and body mass. Thus, 
these findings support the use of the PEG-creatine sup-
plement, at the dosages examined in this investigation, 
as an ergogenic aid for increasing performance in verti-
cal jump, REPBP, and body mass as well as improving 20-
yard shuttle run and 3-cone drill times in untrained indi-
viduals. For strength and conditioning coaches, personal 
trainers, athletic trainers, physical therapists, educators, 
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and other fitness professionals, the present results pro-
vide valuable information pertaining to supplementation 
based on the needs and goals of a client or athlete. For ex-
ample, the current PEG-creatine supplement may be most 
beneficial at the initiation of a conditioning program or 
preseason workout routine during which the client or ath-
lete is in an untrained state. In particular, supplementa-
tion with PEG-creatine may enhance the ability to main-
tain high-intensity exercise, thereby improving training 
capabilities and performance. For the individual involved 
in recreational sports, these findings also suggested that 
PEG-creatine supplementation may improve a number of 
anaerobic performance measures without a concurrent re-
sistance training program. 
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